Daily non-political popular news in brief.

Unique estrogen receptor linked to metastatic breast cancer

Breast cancer awareness month may have passed, but researchers remain focused on the disease with a new study showing that a unique estrogen receptor found in breast cancer tumors is a predictor of tumor size and metastases. The study, led by researchers at Rhode Island Hospital and Brown Medical School, is published in the Nov. 1 issue of Clinical Cancer Research.

Read more »

Keywords: unique, estrogen, receptor, linked, metastatic, breast, cancer

« Previous | Next »

Similar news on "Unique estrogen receptor linked to metastatic breast cancer":

1. Higher physical activity associated with reduced risk of breast cancer
   12-11-2006 · EurekAlert!
   Women with higher levels of physical activity may have a reduced risk of breast cancer after menopause, according to a report in the December 11/25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The association appears to be stronger for estrogen receptor positive/progesterone receptor negative tumors (which are typically more aggressive) than for other types of breast cancer tumors.
   Similar news · Read more »
   
2. Recent declines in breast cancer mortality greatest in women under 70
   04-02-2007 · EurekAlert!
   A new study shows that recent declines in breast cancer mortality rates have been most significant among women with estrogen receptor (ER)-positive tumors and women younger than 70. The results of the study are being published online April 2 in the Journal of Clinical Oncology.
   Similar news · Read more »
   
3. A new computational technique predicts side-effects of a major cancer drug
   11-27-2007 · EurekAlert!
   Researchers at the University of California San Diego have developed a novel computer technique to search for the side effects of major pharmaceuticals. The study, reported Nov. 30 in PLoS Computational Biology, relates to a class of drugs known as Select Estrogen Receptor Modulators, which includes tamoxifen, the most prescribed drug in the treatment of breast cancer.
   Similar news · Read more »
   
4. Findings point to molecular 'Achilles heel' for half of breast cancer tumors
   01-15-2008 · EurekAlert!
   Researchers at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center have shown why a protein known as cyclin D1 may be the Achilles heel for breast tumors that are estrogen receptor positive -- which is the most common type of breast cancer.
   Similar news · Read more »
   
5. New 'knock-out' gene model provides molecular clues to breast cancer
   09-05-2007 · EurekAlert!
   New insights into the role of estrogen receptor in mammary gland development may help scientists better understand the molecular origin of breast cancer, according to new research from the University of Cincinnati.
   Similar news · Read more »
   
6. Study examines the mechanisms that silence the estrogen receptor gene alpha during breast cancer
   08-17-2007 · EurekAlert!
   The mechanisms that silence the estrogen receptor gene alpha (ER-α) in certain breast cancer cell lines may be closer to being unlocked, according to a study by researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine.
   Similar news · Read more »
   
7. Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
   02-15-2008 · EurekAlert!
   How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics -- selective estrogen receptor modulators. V. Craig Jordan, a researcher at the Fox Chase Cancer Center in Philadelphia, Jordan reports on efforts to use the lessons from tamoxifen to develop new hormone receptor-related drugs for both women and men.
   Similar news · Read more »
   
8. Src inhibitors may prove beneficial in breast cancer therapy
   07-12-2007 · EurekAlert!
   Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alpha-negative cancers are more aggressive and have a worse prognosis than do ER-alpha-positive breast cancers, and have been thought to be estrogen independent. In a new JCI study, University of Miami researchers shed further light on the mechanisms regulating ER-alpha expression levels during breast cancer.
   Similar news · Read more »
   
9. New link between estrogen and breast cancer
   08-24-2007 · EurekAlert!
   The female sex hormone estrogen turns on a gene linked to breast cancer, according to new research by Brisbane scientists.
   Similar news · Read more »
   
10. Chemotherapy temporarily affects the structures of the human brain
    11-27-2006 · EurekAlert!
    Researchers have linked chemotherapy with short-term structural changes in cognitive areas of the brain, according to a new study. The study reveals that within 12 months of receiving adjuvant chemotherapy, significant regions of the brain associated with memory, analysis and other cognitive functions were significantly smaller in breast cancer patients who received chemotherapy than those who did not.
    Similar news · Read more »